Unlocking Vision Through Fibulin-3 Research

A $2.2 million NIH grant fuels groundbreaking eye research at the University of Minnesota Medical School, targeting age-related macular degeneration and the rare Doyne honeycomb retinal dystrophy. Scientists are diving deep into retinal proteins—especially fibulin-3—to uncover how they drive vision loss and whether existing FDA-approved drugs could offer new hope. This isn’t just about symptom relief—it’s about solving the root causes to prevent blindness and transform treatment for millions. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/98966e35ac7bc67b